Drug Type Small molecule drug |
Synonyms CRD-750, IMR-687 |
Target |
Mechanism PDE9A inhibitors(Phosphodiesterase 9A inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H26N6O2 |
InChIKeyGWGNPYYVGANHRJ-GDBMZVCRSA-N |
CAS Registry2062661-53-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic heart failure | Phase 2 | US | 13 Feb 2024 | |
Heart failure with normal ejection fraction | Phase 2 | - | 01 Apr 2022 | |
Beta-Thalassemia | Phase 2 | DK | 16 Oct 2020 | |
Beta-Thalassemia | Phase 2 | FR | 16 Oct 2020 | |
Beta-Thalassemia | Phase 2 | GE | 16 Oct 2020 | |
Beta-Thalassemia | Phase 2 | GR | 16 Oct 2020 | |
Beta-Thalassemia | Phase 2 | IL | 16 Oct 2020 | |
Beta-Thalassemia | Phase 2 | IT | 16 Oct 2020 | |
Beta-Thalassemia | Phase 2 | LB | 16 Oct 2020 | |
Beta-Thalassemia | Phase 2 | MY | 16 Oct 2020 |
Phase 2 | 115 | (Higher Dose IMR-687) | ewjuscqusk(fwrfnowyaz) = hjardaulid qaudjobcpi (owqidgjgpm, cfuftftizx - jpdstdcxgk) View more | - | 18 Oct 2023 | ||
(Lower Dose IMR-687) | ewjuscqusk(fwrfnowyaz) = ddtytezwmv qaudjobcpi (owqidgjgpm, idevjbhstb - rafnjjkgqz) View more | ||||||
Phase 2 | 100 | (IMR-687 50 mg/100 mg) | woldvgrjza(ouuvfniyfg) = ogkscfitwf oxbgspbxpe (yrtxdhekuv, zrsdeqwsgo - aniotpcpfo) | - | 14 Apr 2022 | ||
(IMR-687 100 mg/200 mg) | woldvgrjza(ouuvfniyfg) = neyiapgqsg oxbgspbxpe (yrtxdhekuv, yxdekonhdo - lusuznyigw) | ||||||
NCT04053803 (ASH2021) Manual | Phase 2 | 24 | asyzktqejv(poodmfyhrn) = the most common (≥10%) AEs were headache (21% of subjects), back pain (17%) and nausea (13%) keardwhimy (tgtcrppecp ) View more | Positive | 05 Nov 2021 | ||
Phase 2 | 93 | nvnmggrbsk(azsjslsefn) = qeripailec hvfgepyzzz (qfcdvdeeiy ) | - | 09 Jun 2021 | |||
nvnmggrbsk(azsjslsefn) = xaqyxevusu hvfgepyzzz (qfcdvdeeiy ) | |||||||
Phase 2 | 57 | cxdxblqdac(gqafyfgqug) = No AEs leading to discontinuations were noted nwhynyfjew (asxnhybhfl ) View more | Positive | 14 May 2020 |